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Abstract 
Asthma has been known as a prevalent chronic-type inflammatory disease in children, because 
of their narrower respiratory airways. The present study aimed to identify guidelines for children 
asthma treatments. Extensive research was conducted on biomedical and pharmacological 
bibliographic database PubMed, EMBASE, MEDLINE, LILACS database, global independent 
network of Cochrane, Science Direct and global health library of Global Index Medicus. A 
comprehensive literature review was carried out using the terms Pediatric Asthma, 
epidemiology, management, and related clinical guidelines published from 2000 to 2019. After 
the primary assessment, quick diagnosis, clinical practice guidelines are useful tools for proper 
management of pediatric Asthma. By setting proper guidelines for this particular population, a 
higher improvement in quality of management of of pediatric Asthma is expected. Given the 
differences between the recommendations arisen by BTS/SIGN and NICE guidelines, critical 
comparison of the evidence-base guidelines provide suggestions that have more in common than 
what might seems at the first glance. The analysis of the variations presented in the present article 
will assist clinicians to make accurate decisions regarding their patients. 
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 The Emergency Department (ED) duty is the care of 
critically and acutely patients and the Pediatric ED  is 
specialized for infants, children, and teenagers. The 
Pediatric EDs visits is approximately 25% of all 
emergency visits.1 Asthma is a respiratory disease caused 
thousands of deaths every year in the U.S.1 Children, 
because of narrow airways and inhaling more air than 
adults, are the most exposed to asthma.2 It is estimated 
that 9% of all children currently have asthma in this 
country.3 A conventional cause of referrals to emergency 
wards has constantly been asthma among children. 
According to a formal statistics, pediatric asthma 
exacerbations occupy 1.8 million visits to emergency 
wards.4 Asthma carries a significant economic loss due 
to chronic effects. Uncontrolled asthma causes essential 
care of patients frequently in an ED setting.5 The broad 
concern exists about asthmatic treatment in patients; 
there are several guidelines on management of asthma for 
both adults and children. In 1990 for the first time, The 
British Thoracic Society (BTS) made guidelines for 
asthma. Scottish Intercollegiate Guideline Network 
(SIGN) as a first collaborative guideline was published in 
2003 by using evidence-based medicine methodology.6 
After such guidelines became a foundation handling of 
asthma in the United Kingdom, the related updates are 
regularly released every 18–24 months. In 2016, the most 
recent guideline of BTS/SIGN on management of asthma 
was released.6 The national guidelines for emergency 
care of asthma among children, containing prescription 
of oral corticosteroids and reduction of ancillary 
examination including the chest radiograph has been 
published.7 For example, the NAEPP Program which 
stands for National Asthma Education and Prevention 
Program, suggested Primary Care Provider (PCP) and 
systemic care toward children with asthma. The National 
Institute for Health and Care Excellence (NICE) ordered 
guidelines for the diagnosis, monitoring, and 
administration of chronic asthma but after that now some 
national guidelines with some striking differences exist 
for at least England regards of similarities and differences 
in these guidelines can help to clinical care of asthma 
patients. Mainly the asthma exacerbations management 
at an emergency ward is Bronchodilator and systemic 
corticosteroid therapies. This review will focus on 
international and national guidelines for pediatric asthma 
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in an emergency ward/department and children’s asthma 
treatment based on these guidelines in EDs and home of 
discharged patients.6 
Materials and Methods 
Extensive research was conducted on some biomedical 
and pharmacological bibliographic database of life 
sciences such as PubMed, EMBASE, MEDLINE, 
LILACS database, global independent network of 
Cochrane, Science Direct and global health library of 
Global Index Medicus (GIM). By referencing these 
databases, a comprehensive literature review was carried 
out through combining numerous recent studies in terms 
of Pediatric Asthma, epidemiology, management, and 
related clinical guidelines according to articles published 
from 2000 to 2019. Totally 284 articles were checked 
briefly which about 42 of them were deleted due to less 
related content to the objective of the study. Finally, after 
deleting some other articles with subjective weakness 
and adding several other articles through new databases, 
30 articles were separated for extended detailed review. 
For reaching the objectives of this study, the candidate 
articles in terms of evidence-based medicine (EBM), 
management of pediatric asthma in emergency 
departments, asthma, child health, emergency care, and 
clinical practice guidelines were identified. 
Results and Discussion 
Pediatric Asthma epidemiology 
The asthma prevalence has been increased in developed 
countries during the Twentieth century mainly in 
children. As a result, in the 1990s, a series of international 
epidemiological studies on children’s Asthma (e.g. 
International Study of Asthma and Allergies in 
Childhood (ISAAC) has been performed.8-10 These 
studies indicated asthma as a globally-dispersed chronic 
disease with significant prevalence diversity around the 
world. It is currently widely-accepted that prevalence of 
asthma has peeked in developed countries; this is while, 
such an increase may be also constant in low and mid-
income countries.6,11,12 Asthma is a non-communicable 
and globally disease that causes high rate of morbidity as 
well as mortality in serious cases. The prevalence of 
pediatric asthma is more seen among boys. The 
identification among this disease and wheeze 
exacerbations is very hard, especially in young children. 
Wheeze is diagnosed in a third of children with similar 
symptom.s6,13 Exacerbations of periodic wheeze happen 
in many children that must be diagnosed as viral-induced 
wheeze more than asthma, so asthma treatment results 
would be different in this group. The BTS audit (2015) 
indicated the children between one and five years old 
mostly admitted with asthma/wheezy exacerbations. 
Their audit demonstrates most children needed 
hospitalization for less than one day and that 
approximately 40% were administered only in the ED 
and next demobilized to house. Also, they indicated 
smoking as a risk factor which is preventable to a large 
extent. According to the reports issued by National 
Review of Asthma Deaths (NRAD), nearly 25,000 
children with asthma were hospitalization in two years 
(2011-2012). Many risk factors exist that related to 
asthma exacerbations including passive tobacco 
smoking, respiratory tract’s viral infections, allergen 
disposal, age, season, air pollution, gender, and lack of 
immunizations or imperfect immunizations. Asthma 
exacerbations have reached their peak in September 
because of the incidence of a viral illness this month.6,14 
Emergency wards/departments (EDs) are for care of 
patients suffering from critical problems. The area for 
children’s emergency medicine is just for infants, 
childhood, and teenagers care.15 The pediatric EDs 
meeting are nearly 25% of all referring to emergency. 
Studies indicate in 10 years (from 1996 to 2006) the 
pediatric EDs visits number increased by 3% each year. 
30% of pediatric emergency visits are No emergent 
cases, that this no emergent patient requires immediate 
medical care less than 12 hours.4,16,17 The presentation of 
children asthma in clinics generally contains dry cough, 
rale, and breathlessness. Worsening of these symptoms 
indicates an exacerbation of asthma.18 These clinical 
symptoms may relate poorly to asthma exacerbation. So, 
extreme asthma exacerbation in children can seem to be 
well deceitfully. Exacerbations of asthma based on the 
clinical presentation can grade to mild, moderate, acute 
and life-threatening. Measurement such as saturation of 
oxygen, respiratory and peak expiratory flow rate (PEFR) 
can be performed.19 Children with signs similar to asthma 
that usually refer to EDs are summarized in table 1.6 
 
Table 1. Asthma risk factors 
1. Preschool children with viral-induced wheeze 
2. Children presenting for the first time with a new onset of asthma signs and symptoms. 
3. Children with an established diagnosis of asthma that is in exacerbation. 
4. Children presenting with asthma-related issues such as not having a replacement inhaler or inappropriate 
inhaler techniques causing poor response to inhalers administered at home. 
5. Children presenting with status asthmatics, characterized by severity and lack of response to repeated doses of 
inhaled bronchodilators, (severe or life threatening) who may need resuscitation. 
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Emergency Department guidelines 
Asthma-guideline may improve patients’ clinical care.5 
Broading distribution of guidelines systems may help to 
treat asthma.20 National Heart, Lung, and Blood Institute 
(NHLBI) emergency-heightening administration 
guidelines treatment with lung-function testing, peak-
flow readings, and oxygen saturation directly.21, 22 This 
guideline cover a diagram for asthma flow which gives 
common fundamentally and needs local personalization 
to account medications and scoring for personal ED 
varieties. The guidelines of NHLBI  indicate early 
asthma diagnosis symptoms and stratified treatment with 
acute severity.23 Most recently, guidelines of National 
Asthma Education and Prevention Program (NAEPP) 
have been updated in terms of chronic asthma care.24  
BTS/SIGN (2016) guidelines are summarized in Table 2 
for each intensity level of asthma but those guidelines 
must be utilized carefully when do not exist prior asthma 
signs in childhood below the age of two years. These 
guidelines are typically not utilized to asthma 
management for children younger than one year; therefor 
asthma diagnosis in this age is commonly performed with 
the help of a specialist respiratory pediatrician.25 
 The asthma guidelines time nature makes more 
challenges to track. A computerized/automated system 
could help to reduce many challenges that accrue in this 
line. Additionally, there are recommendations of these 
guidelines such as preparation of an Asthma Action Plan 
(AAP) and adding an ICS administration for a discharged 
patient after acute treatment in the emergency ward.21 
The NICE guideline suggests utilizing of the MART 
regimen for youngs 5–16 years old. Bisgaard et al that 
showed lower attacks in children using MART though it 
is acknowledged that no MART is allowed for usage in 
kids at the time of publication. 24 
Clinical guidelines in Emergency Departments for 
children suffering with asthma 
Treatment of children suffering with asthma in 
emergency wards needs analysis and organization of the 
severity of asthma and the excellent performance of a 
coordinated provider team. Acute asthma symptoms in 
patients’ treatment in EDs should be identified early. The 
accuracy of the airway severity obstruction and response 
to therapy should be evaluated. Frequent reevaluation by 
asthma-scoring, peak-flow and oxygen-saturation 
measurement indicates initial asthma-severity rating of 
the patient. Decisions on care are recommended to be 
adjusted to a new level of severity, resulting in a 
disposition decision after each valuation.6,26 
Standardized care in a busy area like an emergency ward 
could be challenging. To provide a suitable treatment 
various asthma guidelines exist. These guidelines have 
general ordering about medications and treating 
clinicians. The primary treatment for those cases 
experienced a mild exacerbation includes a Single Short 
Acting β-Agonist (SABA) inhalation.6,27 For moderate-
to-severe exacerbations of asthma, inhaling of SABA, 
systemic corticosteroids and ipratropium bromide are 
indicated. The patients requiring multiple β-agonist 
treatments and corticosteroids should be visited over a 
specific period after the primary treatment to investigate 
whether more treatment is required or not.6,28 
There is obvious proof that is basic for the primary 
treatments utilized for pediatric asthma exacerbations; 
however, more limited evidence exists for second-line 
treatments, as BTS/SIGN 2016 guidelines (Table 2). The 
consequences of the disease and checkup must not be 
affected by the quick treatment for acute asthma in 
children.29,30 Huge flow oxygen utilizing a snugly-fitting 
face mask must be utilized in children with life-
threatening asthma. The breathed β2 agonist salbutamol 
is the initial therapy in children above two years. β2 
agonists do quickly and we can observe results after four 
to six hours.31 Answer to this kind of treatment could be 
observed utilizing saturations of oxygen and advances in 
clinical investigations, including normalizing of heart, 
rate of respiratory, and saturations of oxygen. β2 agonists 
are supplied through a pressurized metered-dose inhaler 
(PMDI). Weak answer to β2 agonists needs further 
reevaluations.31 In an online survey conducted in the UK 
from 183 emergency clinicians, Lyttle et al. indicated that 
inhaled salbutamol was used by all patients at emergency 
Table2. The intensity of exacerbation for children older than five years, derived from the Sheldon et al.6  
Moderate Acute severe Life-threatening  
» Oxygen saturations ≥92% » Oxygen saturations <92% » Oxygen saturations <92% 
» Peak expiratory flow rate (PEFR) 
>50% best or predicted 
» PEFR 33-50% best or predicted » PEFR <33% best or 
predicted 
» No features of acute/life- threatening 
asthma 
» Unable to complete sentences » Silent chest 
» Cyanosis 




» Heart rate: 
>125/minute (>5 years) 
>140/minute (1-5 years)  
» Respiratory rate: 
>30 breaths/minute (>5 years) >40 
(1-5 years)  
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wards, 63.9% of them had used nebulized salbutamol 
meanwhile patients were hypoxic at presentation and 
PMDI, in case of acceptable saturations.6,32 
A proof base exists for the primary treatments employed 
for pediatric/children’s asthma exacerbations; however, 
more limited evidence exists for second-line treatments 
(Table 2). The examination must not delay children 
treated with an acute asthma exacerbation. Such elements 
are usually implemented through various team organs at 
an equal time.29,30 For children should be used huge flow 
oxygen of a snugly-fitting face mask with SpO2% <94% 
or life-threatening (LT) asthma. The saturation of oxygen 
should reach a rate of 94% to 98% (BTS/SIGN 2016). 
The first-line therapy in children for breathing β2 agonist 
salbutamol is duration of above two years. β2  agonists 
do quickly and the results might take long four to six 
hours.31 Therapeutic answers to β2 agonists can be 
observed utilizing saturations of oxygen and advances in 
clinical investigations, such as heart rate normalization, 
respiratory rate normalization, and oxygen saturation. β2 
agonists are best supplied with a PMDI and spacer and a 
weak answer recommends the reevaluatio.31 The oxygen-
made nebulized salbutamol is usually indicated at regular 
periods for children suffering with life-threatening or 
acute asthma. A reduced answer shows the requirement 
for additional measures at 10-min intervals (20-30min).  
In case of unacceptable reaction to salbutamol at the 
primary presentation, Ipratropium bromide can be 
added.31 Some researchers have inquired the application 
of constant β2 agonist nebulization with salbutamol in a 
comparison to intermittent practice among children and 
thus, continuous type of nebulization is not routinely 
practiced in the United Kingdom.6,33 
Potent evidence exists based on the ipratropium bromide 
treatment at intervals of 20-30min in the beginning 
couple of hours from a severe asthma assault for an extra 
treatment.31 The utilization of ipratropium bromide might 
decrease rates of hospitalization and recover the 
performance of the lung while currently used with a β2 
agonist through the beginning hours of treatment.6,34 In a 
study was discovered that  nearly 44% of centers utilized 
ipratropium quickly with a 38.7% doing it after if the 
primary application of salbutamol showed a weak 
response.6,32 The initial usage of oral administration 
steroids is advised for acute-type asthma cases, 
prednisolone is the opted steroid which frequently takes 
different hours for action.31. Steroids can lower the 
relapse risk and the admission need. IV hydrocortisone 
should be considered for children suffering with acute 
asthma or the children who showed no effective response 
on oral medicine.34 Antibiotics are not recommended to 
be utilized in asthma exacerbations as most maximum is 
occurred by viral infections, however, a BTS audit 
concluded that 28% of the children or teenagers suffering 
with exacerbations use antibiotics.6 Nebulized 
magnesium sulfate serves as a fast bronchodilator, 
although the clinical effectiveness of such a drug has still 
been unknown.6,35 Although there is not any data for the 
control of nebulized magnesium sulfate in mild to 
medium asthma worsening cases, the guidelines of 
BTS/SIGN indicate that there might be some benefits to 
the children holding severe asthma symptoms which 
exhibit oxygen saturations of <92%, however, extra 
investigations are needed. First-line control can be 
reviewed as treatment of hypoxia, administration of 
nebulized β2 agonists (i.e. salbutamol), oral 
corticosteroids (i.e. prednisolone), ipratropium bromide 
and reassessment. The development of second-line 
treatments is required. The mechanisms and suggestions 
of these drugs are briefly presented in Table 3. Among 
children suffering with acute asthma or status 
asthmaticus for whom maximum optimal cure has been 
applied, or the children holding such life-threatening 
symptoms, a pediatrician is needed in order to guide 
patients experiencing second-line treatments in a care 
system which is either high dependency or pediatric 
intensive. Second-line treatments include such 
intravenous medications as aminophylline, salbutamol, 
and magnesium sulfate. Additional investigations are 
required to assess the utility of non-invasive ventilation.6 
Clinical guidelines for Emergency Departments 
treatment for children below 5 years 
Due to limited or absent evident base, a specific issue of 
children under 5 years is guidelines of asthma 
management 36, 37. Two particular problems exist in this 
age: 1) absence of suitable objective tests for guidance of 
either prescription of diagnosis among the children below 
5 years old; 2) the heterogeneous asthma pattern among 
preschool children and different from what os applied for 
adults. Asthma or wheezing attacks are activated through 
viral infections (‘colds’) and mostly, no asthma symptom 
exists between attacks. The most current pattern 
(‘phenotype’) exists up to the age of 3 following to which 
common interval symptoms of chronic asthma will get 
more evident.37 Both BTS/SIGN and NICE emphasize 
that plenty of children below 5 years old with recurrent 
episodes of viral-induced wheezing will not lead to catch 
chronic asthma. None of the guidelines provides us with 
instructions regarding the child experiencing frequent 
wheezing attacks which are treated by oral 
corticosteroids short courses, but do not have any interval 
asthma symptoms.37 
Discharge from emergency ward 
The patients discharged from an emergency ward need 
specific instructions of asthma discharge which 
determine what new medications should be taken by 
patients and what medications are required to continue 
while the primary care provider is followed up.23,38 One 
of the problems of emergency physicians is the question 
“whether to begin ICS for discharged patients or not”, 
while the guidelines recommend to consider adding an 
ICS for patients treated for the acute exacerbation.20. The 
US guidelines propose to apply stepwise treatment 
according to the careful patient age consideration, 
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asthma-control level categorization, impairment and 
risk.20 The guidelines, as well as advocate for the 
preparation of a written AAP, including a considerable 
advice for adding an ICS administration for the children 
discharged followed by acute care in the emergency 
ward.23 About 67% percent of children suffering with 
asthma, and referred to an emergency ward, are classified 
with persistent asthma, while lower than 10% were 
commanded an ICS subsequent to emergency ward 
visit.23,39,40. The benefits of ICS asthma treatment involve 
reducing the death risk of asthma,41 and a relapse 
reduction rate of 45% in comparison to ICS non-
users.23,42. Adherence of provider to guidelines of NHLBI 
in an urban clinic for children with above 3,500 patients 
showed diminished percentages of hospitalization rates 
and emergency visits for treatment of asthma.23 Though 
the most of the emergency physicians/clinicians believe 
that patients with persistent asthma must be treated by 
controller medications,43 emergency visits do not usually 
occur in prescription alteration for chronic or sub-acute 
Table 3. Medicines for pediatric asthma exacerbations 
Drug  Route Dose/frequency according to age When to use  Phar macology  
Salbutamol  Inhaled, 
aerosol  
» Two to ten puffs: each puff is inhaled 
separately, repeat every 10-20 minutes or 
as required, use a large volume spacer  
» Use a snug-fitting face mask in children 
under three years  
» One puff is equivalent to 100mcg  
Mild to moderate 
asthma  
» agonist 2  
» Reverse air-flow 
obstruction  
» Onset of action 
less than five 
minutes  
» Peak action 20-
60 minutes  





One month to four years: 
» 2.5mg every 20-30 minutes or when 
required  
5-11 years:  
» 2.5 to 5 mg every 20-30 minutes  
12-17 years:  
» 5mg every 20-30 minutes  
If improving: 





saturations <92%  
Intravenous 
injection (IV) 
(second line)  
Single bolus dose: 
» 1-23 months: 5mcg/kg over five mins 





Prednisolone  Oral  One month to 12 years old: » 1 to 2mg/kg 
once daily  
(maximum per dose 40mg) for up to three 
days, longer if required  
12-17 years: 
» 40-50mg daily for three to five days  
Moderate, severe 
or life-threatening  
» Corticosteroid 




Nebulised  One month to one years: 
» 250mcg every 20-30 minutes  
for first two hours, then 250mcg every 4-6 
hours as required  
12 to 17 years: 
» 500mcg every 4-6 hours as required  
Severe or life- 
threatening  
» Anticholinergic 
» Onset of action 
20-30 minutes  
Aminophylline  IV  
(second line) 
(patient must 




» 500-700mcg/kg/hr, adjusted to 
plasma-theophylline concentration  













(second line)  
2-17 years old: 
» 40mg/kg (maximum per dose  
2g) to be given over 20 minutes  
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asthma administration. Alternately, emergency providers 
typically rely on the patient to follow-up with a specialist 
of primary care.23,39,44 The most pediatricians (80%) have 
used the fundamental controller medications throughout 
the emergency ward appointment, with benefits of 
providing controller treatment for those who are “lost to 
follow-up” and forcing the adherence importance to 
medications of controller; worries mentioned included 
time deficiency for training in the emergency setting, 
problem to choose the proper controller according to 
level of asthma-control, the reinforcement ED possibility 
utilization instead of the primary care office, lacking any 
connection with physician of the primary care about the 
medication, and also the plan for discharge.23,45 Another 
point that narrows the preparation of ICS is the 
effectiveness of managed care plans which need to 
precede authorization to apply ICS factors. This is a 
distinguishing factor in patients not taking decent 
management because the ED physician does not have the 
time or the required continuity-care documentation 
required to take patient’s previous authorization in order 
to achieve suitable control and management.23,46 
Delivering evidence-based asthma-discharge care in an 
emergency ward deals with characterizing the  
contemporary asthma-control level of the patient and 
administering suitable treatment approach based on 
particular control-level group which was specified in the 
visit. This is a complicated, vibrant, and multistep 
obligation to be employed and work in a busy emergency 
ward, as such a position has some challenges regarding 
contemporary signs, prior exacerbations, including 
hospitalizations, emergency visits, and concomitant 
medicines. A well-planned study on randomized 
controlled trials assessing the efficiency of a Written 
AAP (WAAP) against none concluded that usage of a 
symptom-based method significantly reduces children’s 
visit for critical care of asthma.23,47 The requirement of a 
WAAP after ED visits for asthma was observed to 
significantly raise adherence of the patient to 
commanded acute and controller medicines, as well as 
asthma control.23,48 Nevertheless, a retrospective-type 
review of children referring to an urban emergency 
department specific for children concluded that a WAAP 
was not fixed in a visiting rate of 80%. The preparation 
of a personalized and electronically created WAAP 
accommodates the patient and family with knowledge on 
their contemporary asthma care and provides ED 
physicians and subspecialists with honest, prompt 
communication of discharge advice through visiting the 
patients who follow-up. The demand for a WAAP 
created in the emergency ward is revealed to be in the 
fluctuating rates of 7%–44%49 for pediatric asthma 
follow-up after ED visits.23,50 
Conclusions 
Performing the most suitable health care plans for the 
administration of Pediatric Asthma needs a 
multidisciplinary method in any management phase. 
After the primary assessment, quick diagnosis, clinical 
practice guidelines are useful tools for the proper 
management of pediatric Asthma. By setting the proper 
guidelines for taking the most efficient outcomes for this 
particular population, a higher improvement in the 
quality of management of clinical practice guidelines of 
pediatric Asthma will be achieved. Given the diversities 
and differences between the advices arisen by guidelines 
of BTS/SIGN and NICE, it will be undeniable that severe 
inspection of the evidence-base designates that usually 
more in common exist between the guidelines compared 
to what might seem initially. It is anticipated that such a 
test of the variations concentrated in present article will 
assist the clinicians to make accurate decisions regarding 
their patients. Our knowledge and experiences regarding 
the asthma are expanding and thus our evaluation about 
treatments should be improved as well. More researches 
to illuminate currently insufficient or missing data is 
crucially needed so that updates can provide physicians 
and clinicians with the best possible evidence-based 
recommendations. 
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